NCT00277407

Brief Summary

  1. 1.Purpose of this study is to determine whether NAET procedures are effective in the treatment of children with allergy-related autism spectrum disorders in restoring their verbal and nonverbal communication.
  2. 2.Hypothesis: Children in the experimental group will show a significant improvement over the control group in verbal and nonverbal communication as most food allergen groups, environmental allergen groups, childhood immunizations, and some other relevant allergenic substances are desensitized in a systematic way using NAET® procedures within the specified period of study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 12, 2006

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 16, 2006

Completed
5 months until next milestone

Study Start

First participant enrolled

June 1, 2006

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2007

Completed
Last Updated

May 7, 2007

Status Verified

May 1, 2007

First QC Date

January 12, 2006

Last Update Submit

May 4, 2007

Conditions

Keywords

NAETChiropractic proceduresAcupuncture/acupressureTreatment of Autism by holistic proceduresFood and Vaccination allergy

Outcome Measures

Primary Outcomes (1)

  • Improvement in verbal and norverbal communication

    Twenty-four months from the starting date (approximately may 2008)

Secondary Outcomes (1)

  • Reduction of commonly seen autistic traits

    Twenty-four months from starting dat (May 2008)

Interventions

Eligibility Criteria

Age3 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • all subjects (control and treatment group) should demonstrate typical autistic symptoms before beginning NAET® treatments: made no eye contact, unable to communicate verbally or nonverbally. All subjects should bring in a proof of established diagnosis of autism spectrum disorder by a conventional physician.

You may not qualify if:

  • Any child that has a history of various complications of illness other than autism spectrum disorder would be disqualified. Any patient who has any of the following conditions will also be disqualified.
  • Previous surgeries, congenital deformities of heart, lung, liver, brain, kidney, etc.
  • Any type of cancer
  • Aids
  • Any physically debilitating disorders and diagnosed mental retardation, Down's syndrome, etc.
  • Children with the history of severe allergies or anaphylactic reactions will be exclued.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NAET Pain Clinic

Buena Park, California, 90621, United States

Location

MeSH Terms

Conditions

Autistic DisorderFood Hypersensitivity

Condition Hierarchy (Ancestors)

Autism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Devi S. Nambudripad, DCLAcPhD

    NAR Foundation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 12, 2006

First Posted

January 16, 2006

Study Start

June 1, 2006

Study Completion

May 1, 2007

Last Updated

May 7, 2007

Record last verified: 2007-05

Locations